A new trading day began on Tuesday, with Phathom Pharmaceuticals Inc (NASDAQ: PHAT) stock price down -3.47% from the previous day of trading, before settling in for the closing price of $17.87. PHAT’s price has ranged from $2.21 to $18.28 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 12.50%. Meanwhile, its annual earnings per share averaged 40.26%. With a float of $41.36 million, this company’s outstanding shares have now reached $71.04 million.
The extent of productivity of a business whose workforce counts for 427 workers is very important to gauge.
Phathom Pharmaceuticals Inc (PHAT) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Phathom Pharmaceuticals Inc is 41.86%, while institutional ownership is 50.71%. The most recent insider transaction that took place on Nov 03 ’25, was worth 7,079. In this transaction Principal Accounting Officer of this company sold 524 shares at a rate of $13.51, taking the stock ownership to the 47,407 shares. Before that another transaction happened on Sep 05 ’25, when Company’s Principal Accounting Officer sold 461 for $12.09, making the entire transaction worth $5,573. This insider now owns 47,931 shares in total.
Phathom Pharmaceuticals Inc (PHAT) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -1.05 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.26% per share during the next fiscal year.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Trading Performance Indicators
Here are Phathom Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.81, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -0.60 in one year’s time.
Technical Analysis of Phathom Pharmaceuticals Inc (PHAT)
The latest stats from [Phathom Pharmaceuticals Inc, PHAT] show that its last 5-days average volume of 1.67 million was superior to 1.53 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 86.41%.
During the past 100 days, Phathom Pharmaceuticals Inc’s (PHAT) raw stochastic average was set at 89.69%, which indicates a significant increase from 74.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.90 in the past 14 days, which was higher than the 0.85 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.44, while its 200-day Moving Average is $9.59. Now, the first resistance to watch is $18.12. This is followed by the second major resistance level at $18.98. The third major resistance level sits at $19.66. If the price goes on to break the first support level at $16.58, it is likely to go to the next support level at $15.90. Assuming the price breaks the second support level, the third support level stands at $15.04.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Key Stats
With a market capitalization of 1.23 billion, the company has a total of 71,138K Shares Outstanding. Currently, annual sales are 55,250 K while annual income is -334,330 K. The company’s previous quarter sales were 49,500 K while its latest quarter income was -29,970 K.
